Airway Management in Morbidly Obese Patients: A Comparison of Intubating Laryngeal Mask Fastrack and Air Q as a Conduit for Fiberoptic Intubation

NCT ID: NCT04453683

Last Updated: 2023-01-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-06-20

Study Completion Date

2020-06-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To compare air Q versus ILMA intubation in obese adult paralyzed patient

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Evaluate the process of endo-tracheal intubation through Air Q compared to through ILMA regarding number and duration of attempts, laryngeal view grade, time to removal of device over tube without dislodgement and any complication

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Intubation; Difficult or Failed

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group I ( Air Q)

nsertion of proper size Air-Q. ILA

Group Type ACTIVE_COMPARATOR

Air-Q. ILA insertion of proper size

Intervention Type DEVICE

Success of fiberoptic guided intubation throuhgh Air Q supraglottic airway device

Group II (ILMA)

nsertion of proper size ILMA

Group Type ACTIVE_COMPARATOR

ILMA insertion of proper size

Intervention Type DEVICE

Success of fiberoptic guided intubation throuhgh ILMA supraglottic airway device

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Air-Q. ILA insertion of proper size

Success of fiberoptic guided intubation throuhgh Air Q supraglottic airway device

Intervention Type DEVICE

ILMA insertion of proper size

Success of fiberoptic guided intubation throuhgh ILMA supraglottic airway device

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

ASA physical status (I-II)

Exclusion Criteria

\-
Minimum Eligible Age

20 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Zagazig University

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Heba Mohamed EL -Asser,MD

principal investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Heba M EL-Asser, MD

Role: PRINCIPAL_INVESTIGATOR

Zagazig University

Khadiga M El Hossiney, MD

Role: STUDY_CHAIR

Zagazig University

Amani A Aly

Role: STUDY_CHAIR

Zagazig University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Zagazig University

Zagazig, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

References

Explore related publications, articles, or registry entries linked to this study.

Frappier J, Guenoun T, Journois D, Philippe H, Aka E, Cadi P, Silleran-Chassany J, Safran D. Airway management using the intubating laryngeal mask airway for the morbidly obese patient. Anesth Analg. 2003 May;96(5):1510-1515. doi: 10.1213/01.ANE.0000057003.91393.3C.

Reference Type BACKGROUND
PMID: 12707159 (View on PubMed)

Karim YM, Swanson DE. Comparison of blind tracheal intubation through the intubating laryngeal mask airway (LMA Fastrach) and the Air-Q. Anaesthesia. 2011 Mar;66(3):185-90. doi: 10.1111/j.1365-2044.2011.06625.x.

Reference Type BACKGROUND
PMID: 21320087 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Intubation in morbid obese

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.